ANIX
Price
$3.40
Change
+$0.02 (+0.59%)
Updated
Sep 26 closing price
Capitalization
111.92M
One day until earnings call
SLNCF
Price
$1.45
Change
-$0.15 (-9.38%)
Updated
Sep 24 closing price
Capitalization
205.47M
Interact to see
Advertisement

ANIX vs SLNCF

Header iconANIX vs SLNCF Comparison
Open Charts ANIX vs SLNCFBanner chart's image
Anixa Biosciences
Price$3.40
Change+$0.02 (+0.59%)
Volume$77.64K
Capitalization111.92M
Silence Therapeutics
Price$1.45
Change-$0.15 (-9.38%)
Volume$1.1K
Capitalization205.47M
ANIX vs SLNCF Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. SLNCF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and SLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ANIX: $3.40 vs. SLNCF: $1.45)
Brand notoriety: ANIX and SLNCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 76% vs. SLNCF: 231%
Market capitalization -- ANIX: $111.92M vs. SLNCF: $205.47M
ANIX [@Biotechnology] is valued at $111.92M. SLNCF’s [@Biotechnology] market capitalization is $205.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileSLNCF’s FA Score has 1 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • SLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANIX and SLNCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 6 TA indicator(s) are bullish while SLNCF’s TA Score has 3 bullish TA indicator(s).

  • ANIX’s TA Score: 6 bullish, 4 bearish.
  • SLNCF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANIX is a better buy in the short-term than SLNCF.

Price Growth

ANIX (@Biotechnology) experienced а +3.03% price change this week, while SLNCF (@Biotechnology) price change was -9.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 29, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNCF($205M) has a higher market cap than ANIX($112M). ANIX YTD gains are higher at: 46.552 vs. SLNCF (-44.762). ANIX has higher annual earnings (EBITDA): -13.11M vs. SLNCF (-84.82M). SLNCF has more cash in the bank: 114M vs. ANIX (15.6M). SLNCF has less debt than ANIX: SLNCF (0) vs ANIX (221K). SLNCF has higher revenues than ANIX: SLNCF (27.2M) vs ANIX (0).
ANIXSLNCFANIX / SLNCF
Capitalization112M205M55%
EBITDA-13.11M-84.82M15%
Gain YTD46.552-44.762-104%
P/E RatioN/AN/A-
Revenue027.2M-
Total Cash15.6M114M14%
Total Debt221K0-
FUNDAMENTALS RATINGS
ANIX vs SLNCF: Fundamental Ratings
ANIX
SLNCF
OUTLOOK RATING
1..100
2950
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4787
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNCF's Valuation (26) in the null industry is somewhat better than the same rating for ANIX (70) in the Computer Peripherals industry. This means that SLNCF’s stock grew somewhat faster than ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (77) in the Computer Peripherals industry is in the same range as SLNCF (100) in the null industry. This means that ANIX’s stock grew similarly to SLNCF’s over the last 12 months.

ANIX's SMR Rating (98) in the Computer Peripherals industry is in the same range as SLNCF (98) in the null industry. This means that ANIX’s stock grew similarly to SLNCF’s over the last 12 months.

ANIX's Price Growth Rating (47) in the Computer Peripherals industry is somewhat better than the same rating for SLNCF (87) in the null industry. This means that ANIX’s stock grew somewhat faster than SLNCF’s over the last 12 months.

ANIX's P/E Growth Rating (100) in the Computer Peripherals industry is in the same range as SLNCF (100) in the null industry. This means that ANIX’s stock grew similarly to SLNCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXSLNCF
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 4 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
55%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
64%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGSPY83.050.90
+1.10%
Kingspan Group plc.
ALOD0.25N/A
N/A
Allied Resources, Inc.
FLRAF1.24N/A
N/A
Essentra PLC
GBNXF19.40-0.03
-0.15%
Gibson Energy, Inc.
DTZZF0.05-0.01
-13.66%
Dotz Nano Ltd.

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GLUE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
+0.74%
GLUE - ANIX
42%
Loosely correlated
+14.35%
LGND - ANIX
35%
Loosely correlated
+1.78%
VERA - ANIX
32%
Poorly correlated
+4.60%
KLTO - ANIX
32%
Poorly correlated
-4.65%
ZBIO - ANIX
32%
Poorly correlated
+7.89%
More

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and NAMS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and NAMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
NAMS - SLNCF
24%
Poorly correlated
+8.41%
SANA - SLNCF
22%
Poorly correlated
-1.47%
QLGN - SLNCF
21%
Poorly correlated
-8.33%
APGE - SLNCF
21%
Poorly correlated
+1.87%
ANIX - SLNCF
20%
Poorly correlated
+0.74%
More